Nature Communications (Jan 2019)

RETRACTED ARTICLE: Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression

  • Gui-fang Zhu,
  • Yang-wei Xu,
  • Jian Li,
  • Hui-lin Niu,
  • Wen-xia Ma,
  • Jia Xu,
  • Pei-rong Zhou,
  • Xia Liu,
  • Dan-li Ye,
  • Xiao-rong Liu,
  • Tao Yan,
  • Wei-ke Zhai,
  • Zhi-jun Xu,
  • Chun Liu,
  • Lei Wang,
  • Hao Wang,
  • Jia-mao Luo,
  • Li Liu,
  • Xuan-qi Li,
  • Suiqun Guo,
  • Hui-ping Jiang,
  • Peng Shen,
  • Hui-kuan Lin,
  • Di-hua Yu,
  • Yan-qing Ding,
  • Qing-ling Zhang

DOI
https://doi.org/10.1038/s41467-018-07998-x
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Wilms tumor gene on the X chromosome (WTX) is a putative tumor suppressor gene in Wilms tumor, but its expression and functions in other tumors are unclear. Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in women and the second leading cause in men in the United States. We demonstrated that WTX frequently lost in CRC which was highly correlated with cell proliferation, tumor invasion and metastasis. Mechanistically, WTX loss disrupts the interaction between RhoGDIα and CDC42 by losing of the binding with RhoGDIα and triggers the activation of CDC42 and its downstream cascades, which promotes CRC development and liver metastasis. The aberrant upregulation of miR-20a/miR-106a were identified as the reason of WTX loss in CRC both in vivo and in vitro. These study defined the mechanism how miR-20a/miR-106a-mediated WTX loss regulates CRC progression and metastasis, and provided a potential therapeutic target for preventing CRC progression.